delidecTry the demo →

delidec / Research / CLO

CLO · The Shield BearerLegal Lens2 Jul 2026

Intellectual Property Strategy: Build, License, or Litigate

IP is a decision portfolio, not a legal formality. This paper compares building, licensing, and litigating as strategic options and the conditions that favor each.

The Three Doors Open Onto Different Costs

Build, license, and litigate are not stages of a single process; they are competing claims on the same scarce resources — capital, attention, and time-to-market — and each converts those resources into a different kind of protection. Building means originating the asset yourself: filing patents, prosecuting them, and bearing the multi-year lag between invention and an enforceable grant. Licensing means renting someone else's right, trading a royalty stream and field-of-use limits for speed and certainty. Litigating means spending to convert a paper right into a cash exclusion or settlement. The decision-relevant fact is that these doors price risk differently. A patent you build is an option you have not yet exercised; a license is a hedge purchased at known cost; a suit is a leveraged bet on a tribunal. Treating them as interchangeable "IP work" is the first error, because it hides the fact that you are choosing a risk profile, not a department.

The Mechanism That Actually Protects You

Ask what the right is supposed to do before asking how to acquire it. A patent excludes; it does not confer the freedom to practice. This asymmetry is the single most misunderstood mechanism in IP strategy, and it dictates which door to open. If your goal is to keep a competitor out of a feature, building or buying the blocking patent serves you. If your goal is to ship your own product without being enjoined, you need freedom-to-operate clearance and possibly an inbound license — owning a hundred patents of your own does nothing to lift a rival's blocking claim. The corollary is that trade secrets and patents are substitutes with opposite failure modes: a patent publishes your teaching in exchange for a term-limited monopoly, while a secret lasts indefinitely but evaporates the instant it is independently discovered or reverse-engineered. Choosing between them is really a forecast about whether your advantage is detectable in a shipped product and whether you could prove infringement at all.

Conditions That Favor Each Door

The choice resolves cleanly once a few variables are named: the durability of the underlying advantage, the cost and observability of detecting infringement, your relative litigation endurance, and how close the window of commercial relevance is to the speed of acquisition.

The Failure Mode and the Discipline It Demands

The characteristic failure is litigating from weakness: a startup with a thin patent and a thinner balance sheet sues an incumbent, hoping for a settlement, and instead funds a counterclaim and an inter partes review that invalidates the very asset it was defending. The asymmetry is brutal — the defendant can spend you into a settlement on your own terms, or kill the patent for a fraction of trial cost. The discipline that prevents this is to treat every assertion as a portfolio decision with an expected value, not a moral grievance: estimate the probability of a valid, infringed, surviving claim; multiply by the recoverable amount net of fees; and compare that figure honestly against the licensing offer already on the table. Most IP disputes should settle into a cross-license precisely because litigation's expected value, once discounted for the chance your own right is invalidated, is lower than the negotiated number. The implication for the decision-maker is to keep all three doors visibly open until the variables resolve, and to recognize that the most sophisticated IP move is often declining to build, refusing to sue, and buying the freedom to ship.

← All researchPut a question to the board →